哮喘和慢性阻塞性肺疾病用药现状及新药研究进展  

Current status and new development of drugs for asthma and chronic obstructive pulmonary disease

作　　者：喻勇 宁保明[2] 舒宏 魏宁漪[2] 侯曙光 

机构地区：[1]四川普锐特医药科技有限责任公司,成都610041 [2]中国食品药品检定研究院,北京102629

出　　处：《中国新药杂志》2018年第2期159-166,共8页Chinese Journal of New Drugs

摘　　要：本文简述了哮喘及慢性阻塞性肺疾病的发病机理及全球治疗策略的最新进展,汇总了国内外用于治疗哮喘和慢性阻塞性肺疾病药物的分类、适用性、优劣和市场,并就国外新药研究进展进行了分析及展望。In this chronicobstructive pulmonary current available drug products article, the recent progress of pathogenesis and global therapeutic strategies of disease was introduced, the categories, advantages, limitations, and market of the was summarized, and the trend of new drug development was analyzed and prospected.

关 键 词：哮喘 慢性阻塞性肺疾病 治疗策略 药物类别 研究进展 

分 类 号：R974[医药卫生—药品]